UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Palatability Evaluation of Sulfamethoxazole/Trimethoprim with Sweetener Using the Two-Bottle Choice Test

Chemical and Pharmaceutical Bulletin, 2023/12/01, Vol.71(12), pp.906-908

2023

Volltextzugriff (PDF)

Automated acquisition of explainable knowledge from unannotated histopathology images

Nature communications, 2019-12, Vol.10 (1), p.5642-9, Article 5642

2019

Volltextzugriff (PDF)

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

Japanese journal of clinical oncology, 2019-06, Vol.49 (6), p.506-514

2019

Volltextzugriff (PDF)

Long-Term Oncological Outcomes for Histologically Confirmed High-Risk Prostate Cancer

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2023-04, Vol.90 (2), p.202-209, Article JNMS.2023_90-210

2023

Volltextzugriff (PDF)

A data-driven ultrasound approach discriminates pathological high grade prostate cancer

Scientific reports, 2022-01, Vol.12 (1), p.860-10, Article 860

2022

Volltextzugriff (PDF)

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study

Japanese journal of clinical oncology, 2017-07, Vol.47 (7), p.639-646

2017

Volltextzugriff (PDF)

Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study

International journal of clinical oncology, 2022-01, Vol.27 (1), p.154-164

2022

Volltextzugriff (PDF)

Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study)

Japanese journal of clinical oncology, 2021-06, Vol.51 (6), p.966-975

2021

Volltextzugriff (PDF)

Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up

Japanese journal of clinical oncology, 2020-01, Vol.50 (1), p.12-19

2020

Volltextzugriff (PDF)

Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma

Japanese journal of clinical oncology, 2021-11, Vol.51 (11), p.1656-1664

2021

Volltextzugriff (PDF)

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

International journal of clinical oncology, 2020-08, Vol.25 (8), p.1533-1542

2020

Volltextzugriff (PDF)

Post hoc analysis of Japanese patients from the placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer-updated results

Japanese journal of clinical oncology, 2017-03, Vol.47 (3), p.262-264

2017

Volltextzugriff (PDF)

Differential diagnosis and prognosis of small renal masses: association with collateral vessels detected using contrast-enhanced computed tomography

BMC cancer, 2022-08, Vol.22 (1), p.1-856, Article 856

2022

Volltextzugriff (PDF)

Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2024-04, Vol.91 (2), p.207-217, Article JNMS.2024_91-211

2024

Volltextzugriff (PDF)

Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and Future Directions

Current oncology (Toronto), 2024-01, Vol.31 (2), p.759-768

2024

Volltextzugriff (PDF)

Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care)

BMJ open, 2023-07, Vol.13 (7), p.e070275

2023

Volltextzugriff (PDF)

Factors Associated with Prolonged Retroperitoneal Laparoscopic Radical Nephrectomy Performed by Non-expert Surgeons

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2021-04, Vol.88 (2), p.109-112

2021

Volltextzugriff (PDF)

Urothelial Carcinoma of the Bladder, Lipid Cell Variant: Case Report and Literature Review

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2019-12, Vol.86 (6), p.349-351

2019

Volltextzugriff (PDF)

Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial

Japanese journal of clinical oncology, 2023-01, Vol.53 (1), p.16-25

2023

Volltextzugriff (PDF)

Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study

BMC urology, 2024-05, Vol.24 (1), p.108-108, Article 108

2024

Volltextzugriff (PDF)

Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma

Cancer science, 2017-09, Vol.108 (9), p.1858-1863

2017

Volltextzugriff (PDF)

A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study

International journal of clinical oncology, 2020-04, Vol.25 (4), p.720-731

2020

Volltextzugriff (PDF)

Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study

BMC urology, 2024-03, Vol.24 (1), p.63-63, Article 63

2024

Volltextzugriff (PDF)

Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study

International journal of urology, 2021-07, Vol.28 (7), p.765-773

2021

Volltextzugriff (PDF)

Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial

International journal of clinical oncology, 2019-12, Vol.24 (12), p.1629-1631

2019

Volltextzugriff (PDF)

1 – 25 von 859

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(637)
Mit Volltextzugriff
(721)

Publikationsform

Sprache

Englisch
(729)
Japanisch
(156)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Palatability Evaluation of Sulfamethoxazole/Trimethoprim with Sweetener Using the Two-Bottle Choice Test

Automated acquisition of explainable knowledge from unannotated histopathology images

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

Long-Term Oncological Outcomes for Histologically Confirmed High-Risk Prostate Cancer

A data-driven ultrasound approach discriminates pathological high grade prostate cancer

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study

Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study

Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study)

Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up

Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

Post hoc analysis of Japanese patients from the placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer-updated results

Differential diagnosis and prognosis of small renal masses: association with collateral vessels detected using contrast-enhanced computed tomography

Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis

Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and Future Directions

Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care)

Factors Associated with Prolonged Retroperitoneal Laparoscopic Radical Nephrectomy Performed by Non-expert Surgeons

Urothelial Carcinoma of the Bladder, Lipid Cell Variant: Case Report and Literature Review

Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial

Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study

Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma

A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study

Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study

Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study

Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial

Suchergebnisse filtern